Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02494570
Title A Phase 2 Study of ABI-009 in Patients With Advanced Malignant PEComa
Acronym AMPECT
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Aadi, LLC
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University Medical Center Palo Alto California 94304 United States Details
Sarcoma Oncology Research Center Santa Monica California 90403 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Washington University School of Medicine - Siteman Cancer Center Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Duke University Medical Center - Duke Cancer Center Durham North Carolina 27710 United States Details
University of Texas, MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Washington - Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field